Document is current
Any future updates will be listed below
-
Authors
Fleseriu, Maria https://orcid.org/0000-0001-9284-6289
Barkan, Ariel
del Pilar Schneider, Maria
Darhi, Yannis
de Pierrefeu, Amicie
Ribeiro-Oliveira, Antonio Jr.
Petersenn, Stephan
Neggers, Sebastian
Melmed, Shlomo
-
Funding
Funding for this research was provided by:
Ipsen Biopharmaceuticals
- License Information
-
More Information
Article History
Accepted: 25 November 2021
First Online: 1 January 2022
Declarations
:
: MF: Scientific Consultant for Chiasma, Crinetics, Ionis, Ipsen, Pfizer, and Recordati; Principal Investigator with support to the institution for Chiasma, Crinetics, Ionis, and Novartis; on the Editorial Board of <i>Pituitary</i>; AB: Editor for <i>Pituitary</i>; MdPS: employee of Ipsen; YD: employee of Ipsen; AdP: employee of Ipsen; SP: has been a speaker at workshops and/or Advisory Board Member for Crinetics, Ipsen, Novartis, Pfizer, Recordati, and Takeda; on the Editorial Board of <i>Pituitary</i>; SN: consulting and research fees from Ipsen and Pfizer; consulting fees from Crinetics and Recordati; on the Editorial Board of <i>Pituitary</i>; AROJR: employee of Ipsen; SM: consulting fee; Chiasma, Crinetics, Ionis, Ipsen; funding to institution from Pfizer; Editor-in-Chief for <i>Pituitary</i>.
